Cargando…
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)
Primary hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome caused by impaired lymphocyte cytotoxicity. First‐line therapeutic regimens directed against activated immune cells or secreted cytokines show limited efficacy since they do not target the underlying immunological probl...
Autores principales: | Weißert, Kristoffer, Ammann, Sandra, Kögl, Tamara, Dettmer‐Monaco, Viviane, Schell, Christoph, Cathomen, Toni, Ehl, Stephan, Aichele, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728053/ https://www.ncbi.nlm.nih.gov/pubmed/36278424 http://dx.doi.org/10.15252/emmm.202216085 |
Ejemplares similares
-
Graded Defects in Cytotoxicity Determine Severity of Hemophagocytic Lymphohistiocytosis in Humans and Mice
por: Jessen, Birthe, et al.
Publicado: (2013) -
Cell Versus Cytokine – Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity
por: Wegehaupt, Oliver, et al.
Publicado: (2020) -
Visceral leishmaniasis with hemophagocytic lymphohistiocytosis (HLH)
por: Alkhaldy, Husain Y., et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis (HLH) in a Patient with Disseminated Histoplasmosis
por: Swaminathan, Neeraja, et al.
Publicado: (2020) -
The rare Hematological disorder; A man with Hemophagocytic Lymphohistiocytosis (HLH)
por: Gholizadeh, Majid, et al.
Publicado: (2021)